European doctors along with other organisations call for transparency on public spending and the governance of the APAs. At this crucial stage in the development of one of the main elements of the EU’s response to COVID-19, trust and accountability need to be upheld in order to safeguard and promote public health, the quality of […]

European doctors call for a pharmaceutical strategy that provides citizens with medicines they need at a price they are able to pay. Over time, the trust in the pharmaceutical sector and its ability to promote the development of medical innovations while ensuring sustainable access has been eroded. The confidence in how that system works must […]

What should the priorities of the EU be for the years to come? How do we recover from the crisis and prepare for future challenges? “The last months have taught us how fragile health is.Today more than ever, policy makers, at any level of the European Union, must consider health as a priority when setting […]

On 10 September, the CPME Executive Committee adopted a response to the Health First Europe and European Health Management Survey on ‘Profiling and training the healthcare workers of the future’. The survey to collect views on healthcare professionals’ core competences and policy actions to foster education and training across Europe. CPME noted that the digital […]

On 7 September, CPME issued a statement on online advertising of unhealthy products for the Digital Services Act public consultation. CPME stresses the importance for policy-makers to prioritise the well-being of citizens living in Europe, in particular children and young people, over the financial interests of the marketing industry and take effective regulatory action to […]

European doctors shared their views on a joint strategy of EMA and the Heads of Medicines Agencies for the next five years. We recognise the EMA’s role in increasing transparency and overview of the marketing status of centrally authorised medicines and underline the importance of gathering robust evidence before the approval of any new medicine […]

On 7 August 2020, the CPME Executive Committee adopted the ‘CPME Response to the eHealth Stakeholders Group on First Year Priorities’ (CPME 2020/065 FINAL).

‘’While we are glad to see that European leaders reached a compromise agreement, we are greatly disappointed about the enormous cuts in the health budget” commented CPME President Prof. Dr Frank Ulrich Montgomery on the outcome of the European Council 17-21 July 2020. Over the past months policy makers all over the European Union strongly […]

On 9 July 2020, the CPME Executive Committee adopted the ‘CPME response to the EUHealthSupport Stakeholder Survey’ (CPME 2020/059 FINAL).

On 9 July May 2020, the CPME Executive Committee adopted the ‘CPME response to the Digital Doc Thematic Network Survey on Challenges, Recommendations and Best Practices’ (CPME 2020/060 FINAL). CPME believes that the digital transformation of medicine should be understood by all actors as a long-lasting disruptive process of change and innovation that will massively […]